Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vanessa Ribeiro Moreira"'
Autor:
Bruno Araújo Serra Pinto, Thamys Marinho Melo, Karla Frida Torres Flister, Lucas Martins França, Vanessa Ribeiro Moreira, Daniela Kajihara, Nelmar Oliveira Mendes, Silma Regina Pereira, Francisco Rafael Martins Laurindo, Antonio Marcus Andrade Paes
Publikováno v:
Antioxidants, Vol 11, Iss 7, p 1395 (2022)
Metabolic dysfunctions, such as hyperglycemia and insulin resistance, have been associated to cognitive impairment and dementia regardless of advanced age, although the underlying mechanisms are still elusive. Thus, this study investigates the delete
Externí odkaz:
https://doaj.org/article/bea07904bddb45c7ab03381be14244a0
Autor:
Muryllo Santos Castro, Patrícia Valéria Castelo-Branco, Ricardo Luvizotto-Santos, V L M Silva, Luis Fernando Carvalho-Costa, Vanessa Ribeiro Moreira, Silma Regina Ferreira Pereira
Publikováno v:
Brazilian Journal of Biology, Iss 0 (2018)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c9f9ebcefebab69cb96c184ca8c1a24
https://pubmed.ncbi.nlm.nih.gov/30133558
https://pubmed.ncbi.nlm.nih.gov/30133558
Autor:
Luís Cláudio Lima de Jesus, Bruno Araújo Serra Pinto, Luis Douglas Miranda Silva, Maria Norma Melo, Vanessa Ribeiro Moreira, Antonio Marcus de Andrade Paes, Rossy-Eric Pereira Soares, Silma Regina Ferreira Pereira
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
Leishmaniasis is a neglected tropical disease caused by >20 species of the protozoan parasite Leishmania . Meglumine antimoniate (Glucantime) is the first-choice drug recommended by the World Health Organization for the treatment of all types of leis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9b493f3365279897684521d869d423f
https://doi.org/10.1128/aac.02360-16
https://doi.org/10.1128/aac.02360-16
Autor:
Luís Cláudio Lima de Jesus, Hugo José Alves, Vera Lucia Maciel Silva, Marta Regina de Castro Belfort, Silma Regina Ferreira Pereira, Vanessa Ribeiro Moreira, Rossy-Eric Pereira Soares, Patrícia Valéria Castelo Branco
Publikováno v:
Mutation research. Genetic toxicology and environmental mutagenesis. 806
Miltefosine was developed to treat skin cancer; further studies showed that the drug also has activity against Leishmania. Miltefosine is the first oral agent for treating leishmaniasis. However, its mechanism of action is not completely understood.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::817f790a943db69ce393e90cec4799c1
https://pubmed.ncbi.nlm.nih.gov/27476333
https://pubmed.ncbi.nlm.nih.gov/27476333